Sign in
Taking peopleNo phase

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Key facts

Who runs it
Abbott Medical Devices
Where
Durham and Madison, United StatesSee the 2 sitesAlso in 6 other countries, 15 sites
Trial code
Status
Recruiting
People taking part
550 people, planned
Started
1 Feb 2021
Expected to end
Mar 2031
Type of study
Observational, 5 groups
Treatments tested
  • Abbott SJM Rigid Saddle Ring
  • Abbott SJM Séguin Ring
  • Abbott SJM Tailor Ring
  • Abbott SJM Tailor Band
Record updated
18 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Subject is expected to undergo cardiac surgery in ≤90 days including at least one of the following:; implant of a Rigid Saddle Ring, Séguin Ring or a full Tailor Ring without cut zone removal for MR repair; implant of a full Tailor Ring without cut zone removal for TR repair, or; implant of a Tailor Band or partial Tailor Ring with cut zone removed for primary TR repair
  • Subject's cardiac surgery will be performed by a study investigator
  • Subject will be ≥18 years old at the time of their annuloplasty implant(s)
  • Subject provides written informed consent and agrees to comply with all required study visits and procedures

Who cannot take part

  • Subject is expected to have active endocarditis at the time of their Abbott annuloplasty device implant(s)
  • Subject cannot be unambiguously assigned to a treatment group due to missing data on repair indication(s) or the model and configuration (cut zone removed or not) of their Abbott annuloplasty implant(s)
  • Subject is unable to read or write or has a mental illness or disability that impairs their ability to provide written informed consent
  • Subject has anomalous anatomy or medical, surgical, psychiatric or social history or conditions that, in the investigator's opinion, would limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements
  • Subject is below the age of legal consent in the applicable jurisdiction or otherwise lacks legal authority to provide informed consent
  • Subject is participating in another clinical investigation including any treatment outside the investigative site's usual standard of care

Where in United States

Also in 6 other countries, 15 sites

  • Duke University HospitalDurham, United StatesContact: Karine MiquelNo longer taking part
  • University of Wisconsin Hospital and ClinicsMadison, United StatesContact: Karine MiquelNo longer taking part

About the trial

What the trial wants to find out

ARB-PMCF is a multicenter, observational study of the safety and performance of Abbott annuloplasty devices used in surgical repair of mitral and tricuspid valve regurgitation. The devices included in this study are the SJM™ Rigid Saddle Ring and SJM Séguin Annuloplasty Ring, indicated for mitral valve repair, and the SJM Tailor™ Annuloplasty Ring and SJM Tailor Annuloplasty Band, indicated for mitral or tricuspid repair. Participants will be enrolled prior to undergoing mitral or tricuspid valve repair surgery including an Abbott annuloplasty implant and will complete annual follow-up visits through five years from implant. The study is being conducted to meet post-market clinical follow-up requirements of the European Union Medical Device Directives.

The 5 groups in the trial

  • Group 1: Primary mitral disease repair surgery with an Abbott annuloplasty ring implant

    Group 1 will enroll 200 subjects undergoing surgical repair of primary mitral regurgitation that includes annuloplasty with an Abbott SJM Rigid Saddle Ring, Séguin Ring or full Tailor Ring without cut zone removal. Enrollment must include at least 50 subjects implanted with each ring model. In primary mitral regurgitation, backflow through the closed valve is caused by disease intrinsic to the mitral valve tissue itself.

    Treatment: Abbott SJM Rigid Saddle Ring, Abbott SJM Séguin Ring, and Abbott SJM Tailor Ring

  • Group 2: Secondary mitral disease repair surgery with an Abbott annuloplasty ring implant

    Group 2 will enroll 200 subjects undergoing surgical repair of secondary mitral regurgitation that includes annuloplasty with an Abbott SJM Rigid Saddle Ring, Séguin Ring or full Tailor Ring without cut zone removal. Enrollment must include at least 50 subjects implanted with each ring model. In secondary mitral regurgitation, backflow through the closed valve is secondary to diseases of the surrounding myocardium, rather than caused by disease of the valve tissue itself.

    Treatment: Abbott SJM Rigid Saddle Ring, Abbott SJM Séguin Ring, and Abbott SJM Tailor Ring

  • Group 3: Primary tricuspid disease repair surgery with a full Tailor Ring implant

    Group 3 will enroll up to 50 subjects undergoing surgical repair of primary tricuspid regurgitation that includes annuloplasty with a full Abbott SJM Tailor Ring without cut zone removal. In primary tricuspid regurgitation, backflow through the closed valve is caused by disease intrinsic to the tricuspid valve tissue itself.

    Treatment: Abbott SJM Tailor Ring

  • Group 4: Secondary tricuspid disease repair surgery with a full Tailor Ring implant

    Group 4 will enroll up to 50 subjects undergoing surgical repair of secondary tricuspid regurgitation that includes annuloplasty with a full Abbott SJM Tailor Ring without cut zone removal. In secondary tricuspid regurgitation, backflow through the closed valve is secondary to diseases of the surrounding myocardium, rather than caused by disease of the valve tissue itself.

    Treatment: Abbott SJM Tailor Ring

  • Group 5: Primary tricuspid disease repair surgery with a partial Tailor Ring or Tailor Band implant

    Group 4 will enroll up to 50 subjects undergoing surgical repair of secondary tricuspid regurgitation that includes posterior annuloplasty with either a partial Abbott SJM Tailor Ring with cut zone removed or an Abbott SJM Tailor Band. In primary tricuspid regurgitation, backflow through the closed valve is caused by disease intrinsic to the tricuspid valve tissue itself.

    Treatment: Abbott SJM Tailor Ring and Abbott SJM Tailor Band

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Annuloplasty Rings and Band Post-Market Clinical Follow-Up (ARB-PMCF) Study
Record updated
18 May 2026